- Bevorzugter Name
- (2S,3R,4S,5R,6R)-3-[(2R,3R,4S,6S)-4-amino-6-[[(1S)-3-[(2R)-2-amino-2-carboxyethyl]sulfanyl-1-carboxypropyl]carbamoyl]-3-hydroxyoxan-2-yl]oxy-4-(carbamoylamino)-6-[(1S)-2-(2,4-dioxo-1H-pyrimidin-5-yl)-1,2-dihydroxyethyl]-5-hydroxyoxane-2-carboxylic acid
- IUPAC
- (2S,3R,4S,5R,6R)-3-[(2R,3R,4S,6S)-4-amino-6-[[(1S)-3-[(2R)-2-amino-2-carboxyethyl]sulfanyl-1-carboxypropyl]carbamoyl]-3-hydroxyoxan-2-yl]oxy-4-(carbamoylamino)-6-[(1S)-2-(2,4-dioxo-1H-pyrimidin-5-yl)-1,2-dihydroxyethyl]-5-hydroxyoxane-2-carboxylic acid
- Englischer Name
- EZOMYCIN D1
- Summenformel
- C26H39N7O17S
- Molmasse
- 753.69
Namen und Synonyme
SCHEMBL2988527257973-15-6EZOMYCIN D1L-erythro-L-gluco-Octonic acid, 3-O-[3-amino-N-[(1S)-3-[[(2R)-2-amino-2-carboxyethyl]thio]-1-carboxypropyl]-3,4-dideoxy-β-D-xylo-hexopyranuronamidosyl]-4-[(aminocarbonyl)amino]-2,6-anhydro-4-deoxy-8-C-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)- (9CI)